Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
603
-
Total 13F shares, excl. options
-
72.8M
-
Shares change
-
-94.3K
-
Total reported value, excl. options
-
$20.2B
-
Value change
-
-$57M
-
Put/Call ratio
-
1.07
-
Number of buys
-
293
-
Number of sells
-
-281
-
Price
-
$277.40
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2019
742 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2019.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 603 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.8M shares
of 105M outstanding shares and own 69.35% of the company stock.
Largest 10 shareholders include Capital World Investors (8.21M shares), BlackRock Inc. (6.26M shares), VANGUARD GROUP INC (6.2M shares), HARRIS ASSOCIATES L P (4.14M shares), LOOMIS SAYLES & CO L P (3.59M shares), STATE STREET CORP (3.53M shares), FMR LLC (2.73M shares), ALLIANCEBERNSTEIN L.P. (2.12M shares), WELLINGTON MANAGEMENT GROUP LLP (1.77M shares), and POLEN CAPITAL MANAGEMENT LLC (1.64M shares).
This table shows the top 603 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.